This doesn't mean they're dangerous or ineffective, but it does mean: Limited clinical data: Without the trials required for approval, human data remains sparse
Beyond GLP-1, the market encompasses peptide cancer therapies (Oncology Peptide Therapy at 4.1% share, 11.79% CAGR), somatostatin analogues for neuroendocrine tumours, GnRH agonists/antagonists for hormone-sensitive cancers, radioligand therapy, and reproductive medicine peptides each representing strategically important niches with their own competitive dynamics
Early medical assessment is important because ED can be an early indicator of underlying health conditions, particularly cardiovascular disease, diabetes, or hormonal imbalances
Psychotherapy and magnetic stimulation therapy are two effective treatments that can be used with vitamin B12 supplementation